OC
Owens Corning Materials Abrasive, Asbestos & Misc Nonmetallic Mineral Prods Russell 3000
$121.15Close
$9.7BMarket cap
$96.37 – $158.9252-week range
Nov 4, 2026Next report · before the open
Highlights
Cautions
- Not in an uptrend 3 of 8 trend conditions
- Lagging the market RS 33 · weaker than 67% of stocks over 12 months
- Distribution down-day volume 1.6× up-day volume over 50 sessions
- Earnings shrinking EPS −34% year on year
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
24%
1wk
up 6.1%
price change
1mo
up 4.5%
price change
12-month return
down 1%
market up 11% ·
its own down 12%
F-score
4 / 9
Weak
Altman Z
2.06
Moderate risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
2.5×
price / book
Earnings yield
up 2.6%
EBIT / enterprise value
Cheaper than
64%
of the market · cheap
Revenue growth
up 3%
year on year
EPS growth
down 34%
latest quarter
Sales growth
0%
latest quarter · +11 pts
ROE
down 12%
return on equity
Free cash margin
up 10%
$962.0M FCF
D/E
1.22
long-term debt / equity
Net debt / EBITDA
4.1×
Interest cover
1.4×EBIT / interest
Piotroski tests
- not yet profitable on its assets
- profitability slipped from last year
- short-term liquidity weakened
- gross margin narrowed
- assets working less efficiently
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- no new shares issued
Repair signals
- Long-term debt down 7% ($5.1B → $4.7B)
Trade setup
ATR%
3.5%
$4.24 a day · 2×ATR $112.67
RS
33 / 99
vs the universe
Trend
3 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
0.63
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Contractions
2
22% → 18%
Pivot
$131.83
8.1% below
Volume dry-up
0.8×
10 vs 50 sessions
Trend template · 3 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: fails
- Price above the 50-day average: fails
- At least 30% above the 52-week low: fails
- Within 25% of the 52-week high: passes
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Material impairment The company disclosed a material impairment - an asset written down below the value the balance sheet had been carrying.
- Interest is covered, but thinly Earnings before interest cover the interest bill 1.4 times, leaving little room if profits fall.
- Heavily indebted Net debt is 4.1 times EBITDA — roughly 4 years of earnings before interest, tax and depreciation to repay borrowings in full.
- Gross margin narrowing Gross margin fell from 30.9% to 28.1%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported
Aug 5, 2026
Results reaction
Aug 5, 2026+4% vs market2 sessions after results
Financials
- Gross 28%
- Net -5%
- Free cash 10%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $7.1B | $8.5B | $9.8B | $8.4B | $9.9B | $10.1B |
| Gross margin | 23% | 26% | 27% | 29% | 31% | 28% |
| Operating income | -$138.0M | $1.4B | $1.7B | $1.6B | $1.5B | $360.0M |
| Net income | -$383.0M | $995.0M | $1.2B | $1.2B | $647.0M | -$522.0M |
| Net margin | -5% | 12% | 13% | 14% | 7% | -5% |
| Earnings per share | -$3.53 | $9.54 | $12.70 | $13.14 | $7.37 | -$6.21 |
| Free cash flow | $828.0M | $1.1B | $1.3B | $1.2B | $1.2B | $962.0M |
| Free cash margin | 12% | 13% | 13% | 14% | 13% | 10% |
| Cash | $717.0M | $959.0M | $1.1B | $1.6B | $321.0M | $345.0M |
| Long-term debt | $3.1B | $3.0B | $3.0B | $2.6B | $5.1B | $4.7B |
| Shareholders' equity | $3.9B | $4.3B | $4.6B | $5.2B | $5.1B | $3.9B |
| Shares outstanding | 105.60m | 100.40m | 91.90m | 87.20m | 85.40m | 80.20m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Feb 25, 2026 | Annual ↗ | Dec 31, 2025 | 56d |
| Nov 5, 2025 | Quarterly ↗ | Sep 30, 2025 | 36d |
| Aug 6, 2025 | Quarterly ↗ | Jun 30, 2025 | 37d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 24, 2025 | Annual ↗ | Dec 31, 2024 | 55d |
| Nov 6, 2024 | Quarterly ↗ | Sep 30, 2024 | 37d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| Apr 24, 2024 | Quarterly ↗ | Mar 31, 2024 | 24d |
| Feb 14, 2024 | Annual ↗ | Dec 31, 2023 | 45d |
| Oct 25, 2023 | Quarterly ↗ | Sep 30, 2023 | 25d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 16, 2026 | Director or officer change ↗ |
| Aug 5, 2026 | Results ↗ |
| Jul 29, 2026 | Director or officer change ↗ |
| May 6, 2026 | Results ↗ |
| May 1, 2026 | Director or officer change ↗ |
| May 1, 2026 | Other events ↗ |
| Apr 20, 2026 | Shareholder vote ↗ |
| Apr 15, 2026 | Impairment · Other events ↗ |
| Feb 25, 2026 | Results ↗ |
| Feb 6, 2026 | Director or officer change ↗ |
| Nov 5, 2025 | Results ↗ |
| Aug 6, 2025 | Results ↗ |